Graphical user interface for monitoring and controlling use of medical devices
    35.
    发明授权
    Graphical user interface for monitoring and controlling use of medical devices 有权
    用于监控和控制医疗设备使用的图形用户界面

    公开(公告)号:US08845632B2

    公开(公告)日:2014-09-30

    申请号:US13084973

    申请日:2011-04-12

    CPC classification number: A61B18/12 A61B18/18 A61B2018/00267

    Abstract: A device for treating a tissue region is supplied with a separate usage key card. The usage key card comprises a storage medium, which is formatted to contain an identification code unique to the usage key card. The usage key card is adapted to be read by a remote reader, to download the identification code for processing by a controller for the device. Processing of the identification code by the controller either enables or disables operation of the device according to prescribed criteria. A viewable image is generated on a display screen that changes in response to processing of the identification code.

    Abstract translation: 用于处理组织区域的装置被提供有单独的使用密钥卡。 使用密钥卡包括被格式化为包含使用密钥卡唯一的识别码的存储介质。 使用密钥卡适于由远程读取器读取,以便下载用于设备的控制器进行处理的识别码。 由控制器处理识别码可以根据规定的条件启用或禁用设备的操作。 响应于识别码的处理而改变的显示画面上生成可视图像。

    Systems and methods for applying a selected treatment agent into contact with tissue
    40.
    发明授权
    Systems and methods for applying a selected treatment agent into contact with tissue 有权
    将选定的处理剂施用于与组织接触的系统和方法

    公开(公告)号:US08161976B2

    公开(公告)日:2012-04-24

    申请号:US11906457

    申请日:2007-10-02

    Abstract: Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.

    Abstract translation: 通过将一种或多种治疗剂施用于存在异常神经症状或异常组织病状的区域处或附近的组织来治疗胃肠道疾病的系统和方法。 选择治疗剂以破坏异常神经通路和/或减轻异常组织状况。 治疗剂可以包括至少一种细胞因子和/或至少一种香草酸化合物以引起所需的组织应答。 系统和方法可以用作主要治疗方式,或作为新辅助治疗方式。

Patent Agency Ranking